Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Physician
Patient
Health Care Practitioner
Pharma / Biotech Industry
Other
Topics:
Rheumatology
•
Infection-related arthritis
How do you differentiate between chikungunya-induced arthritis and RA during sporadic outbreaks or in regions with higher prevalence?
Related Questions
How do you focus your history and exam to better identify potential cases of chikungunya presenting with rheumatic symptomas in the setting of global travel?
What strategies do you implement in your clinic to ensure comprehensive screening and timely diagnosis of syphilis in populations with risk factors for sexually transmitted infections?
What specific criteria or patient conditions would make you hesitant to use fluoroquinolones early in the treatment course for managing MSSA joint infections with oral antibiotics?
How often do you see bony erosions in patients with Lyme arthritis?
How do you integrate next-generation sequencing with traditional culture methods to improve the identification of fungal pathogens, especially in cases where routine cultures are negative when evaluating suspected prosthetic joint infections?
How do you counsel patients with dermatomyositis on sun protection?
Where do you anticipate using bimekizumab in your sequence of treatment options for a patient with psoriatic arthritis?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
If subdeltoid bursitis, bicipital tenosynovitis, and femoroacetabular synovitis are commonly present in PMR, why are they not included in the criteria for PMR and how are they differentiated from elderly onset RA where presentation is often atypical and more proximal?
What is your approach to differentiating tender spots (as in fibromyalgia) and enthesitis (as in axSpA)?
